Articles by Erin Slifka

Fintech startup Affirm is postponing its initial public offering, the second company in as many days to pull back from the red-hot IPO market.

Pfizer is packing boxes with thousands of its Covid-19 vaccines for shipment around the U.S., as hospitals gear up to give shots while also confronting the surging pandemic.

As the pandemic has affected scheduling and sidelined some star players, TV networks are forced to restructure deals with advertisers to make up for smaller audiences.

The move would bolster the drug giant’s footprint in rare diseases, and comes at a pivotal time for the company, which is in late-stage development of a Covid-19 vaccine.

Microsoft is on top, followed by Apple, IBM and Amazon in the Drucker Institute’s annual Management Top 250 ranking.

The vaccine is the first to gain the federal government’s permission to go into use in the U.S., a landmark step in efforts to beat back the raging coronavirus pandemic.

The state filed court papers seeking to join the Justice Department suit alleging that Google violated federal antitrust laws by entering into exclusionary business agreements that shut out competitors and suppressed innovation.

The database company said it has changed its corporate headquarters to Austin, Texas, the latest high-profile defection from Silicon Valley.

The initial public offerings this week of DoorDash and Airbnb cap a string of listings that have helped make this the most lucrative year on record for IPOs in terms of money raised, showering returns on some of the biggest names in tech investing.